Faculty of Health Sciences, University of Bamenda, Bamenda, Cameroon.
Buea Regional Hospital, Buea, Cameroon.
BMC Nephrol. 2022 Jan 3;23(1):8. doi: 10.1186/s12882-021-02641-2.
Kidney dysfunction is common in patients with heart failure (HF) and has been associated with poor outcomes. This study aimed to determine the prevalence, correlates, and prognosis of kidney dysfunction in patients with HF in Cameroon, an understudied population.
We conducted a cross-sectional study in consecutive patients hospitalized with HF between June 2016 and November 2017 in the Buea Regional Hospital, Cameroon. Kidney dysfunction was defined as an estimated glomerular filtration rate < 60 ml/min/1.73m. Prognostic outcomes included death and prolonged hospital stay (> 7 days). We also performed a sensitivity analysis excluding racial considerations.
Seventy four patients (86.1% of those eligible) were included. Their median age was 60 (interquartile range: 44-72) years and 46.0% (n = 34) were males. Half of patients (n = 37) had kidney dysfunction. Correlates of kidney dysfunction included previous diagnosis of HF (adjusted odds ratio [aOR]4.3, 95% CI: 1.1-17.5) and left ventricular hypertrophy (aOR3.4, 95% CI: 1.1-9.9). Thirty-six (48.9%) had prolonged hospital stay, and seven (9.5%) patients died in hospital. Kidney dysfunction was not associated with in-hospital death (aOR 0.4, 95% CI: 0.1-2) nor prolonged hospital stay (aOR 2.04, 0.8-5.3). In sensitivity analysis (excluding racial consideration), factors associated with Kidney dysfunction in HF were; anemia (aOR: 3.0, 95% CI: 1.1-8.5), chronic heart failure (aOR: 4.7, 95% CI: 0.9-24.6), heart rate on admission < 90 bpm (aOR: 3.4, 95% CI: 1.1-9.1), left atrial dilation (aOR: 3.2, 95% CI: 1.04-10), and hypertensive heart disease (aOR: 3.1, 95% CI: 1.2-8.4). Kidney dysfunction in HF was associated with hospital stay > 7 days (OR: 2.6, 95% CI: 1-6.8).
Moderate-to-severe kidney dysfunction was seen in half of the patients hospitalized with HF in our setting, and this was associated with a previous diagnosis of HF and left ventricular hypertrophy. Kidney dysfunction might not be the main driver of poor HF outcomes in this population. In sensitivity analysis, this was associated with anemia, chronic heart failure, heart rate on admission less than 90 bpm, left atrial dilatation, and hypertensive heart disease. Kidney dysfunction was associated with hospital stay > 7 days.
肾功能障碍在心力衰竭(HF)患者中很常见,并且与不良预后相关。本研究旨在确定喀麦隆心力衰竭患者肾功能障碍的患病率、相关因素和预后,喀麦隆是一个研究不足的人群。
我们对 2016 年 6 月至 2017 年 11 月在喀麦隆布埃亚地区医院因 HF 住院的连续患者进行了横断面研究。肾功能障碍定义为估算肾小球滤过率<60ml/min/1.73m。预后结局包括死亡和住院时间延长(>7 天)。我们还进行了一项敏感性分析,排除了种族因素的影响。
共纳入 74 例患者(符合条件的患者中有 86.1%)。他们的中位年龄为 60 岁(四分位间距:44-72 岁),46.0%(n=34)为男性。一半的患者(n=37)有肾功能障碍。肾功能障碍的相关因素包括既往 HF 诊断(调整后优势比[aOR]4.3,95%可信区间:1.1-17.5)和左心室肥厚(aOR3.4,95%可信区间:1.1-9.9)。36(48.9%)患者住院时间延长,7(9.5%)患者住院期间死亡。肾功能障碍与院内死亡无关(aOR 0.4,95%可信区间:0.1-2)或住院时间延长(aOR 2.04,95%可信区间:0.8-5.3)。在敏感性分析(排除种族因素)中,HF 患者肾功能障碍的相关因素包括:贫血(aOR:3.0,95%可信区间:1.1-8.5)、慢性心力衰竭(aOR:4.7,95%可信区间:0.9-24.6)、入院时心率<90bpm(aOR:3.4,95%可信区间:1.1-9.1)、左心房扩张(aOR:3.2,95%可信区间:1.04-10)和高血压性心脏病(aOR:3.1,95%可信区间:1.2-8.4)。HF 患者的肾功能障碍与住院时间>7 天有关(OR:2.6,95%可信区间:1-6.8)。
在我们的研究中,一半因 HF 住院的患者存在中重度肾功能障碍,这与 HF 既往诊断和左心室肥厚相关。在该人群中,肾功能障碍可能不是 HF 不良结局的主要驱动因素。在敏感性分析中,它与贫血、慢性心力衰竭、入院时心率<90bpm、左心房扩张和高血压性心脏病相关。肾功能障碍与住院时间>7 天有关。